Occudo Quantitative Strategies LP Adma Biologics, Inc. Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $824,419 - $1.26 Million	-187,368 Reduced 94.24%	11,453 $75,000
Q4 2023 Feb 14, 2024	BUY	$3.08 - $4.52 $612,368 - $898,670	198,821 New	198,821 $898,000
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $83,809 - $113,357	26,862 Added 23.42%	141,556 $522,000
Q1 2023 May 15, 2023	SELL	$3.01 - $3.87 $99,570 - $128,019	-33,080 Reduced 22.39%	114,694 $379,000
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $237,371 - $372,875	-96,102 Reduced 39.41%	147,774 $573,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $423,776 - $597,045	208,757 Added 594.43%	243,876 $593,000
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $50,220 - $77,261	35,119 New	35,119 $70,000

319

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.85B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.